Comparing the current results to its competitors, Scientific Industries Inc reported Revenue decrease in the 2 quarter 2026 year on year by -36.89 %, despite the revenue increase by the most of its competitors of 30.15 %, recorded in the same quarter.
Scientific Industries Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 12.9 %
Scientific Industries Inc 's Comment on Competition and Industry Peers
The Company competes primarily with larger firms that have greater financial, production, and marketing resources. Competition is based on technical specifications, price, and product recognition and acceptance. For its Torbal® brand products, main competitors include Ohaus Corporation, A&D Company Ltd., Adam Equipment Co., Ltd., Illinois Tool Works, and Capsa Healthcare. Competitors for the VIVID® brand automated pill counters include Capsa Healthcare and Medility Inc. Direct competitors for the Bioprocessing Systems products are ABER Instruments and PreSens GmbH. Indirect competitors include Hamilton Bonaduz AG, optek-Danulat GmbH, Sartorius AG, and Eppendorf SE.
Publicly Traded Peers of Scientific Industries Inc
Agilent Technologies inc Share Performance
+9.36%
This Year
Agilent Technologies inc
Profile
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Bio-Rad Laboratories Inc operates as a global leader in life sciences and clinical diagnostics by focusing on the development, manufacturing, and distribution of a diverse array of products and solutions. Their business model emphasizes innovation, providing advanced tools and technologies that empower scientists and healthcare professionals to effectively analyze biological materials. By delivering high-quality solutions, Bio-Rad aims to facilitate scientific breakthroughs and enhance patient care in various healthcare settings.
Avantor Inc's business model revolves around providing a wide range of products, services, and solutions to customers in the life sciences, advanced technologies, and applied materials sectors. They focus on delivering a comprehensive offering, including chemicals, lab equipment, consumables, and customized solutions, to support research, development, and production processes.
10x Genomics Inc is a biotechnology company that specializes in providing tools and solutions for genomic research. Their business model revolves around developing innovative technologies and platforms to enable scientists and researchers to gain deeper insights into the structure and function of biological systems. They offer products such as single-cell sequencing and spatial transcriptomics to support various areas of genomics research and accelerate discoveries in fields like cancer research, immunology, and neuroscience.
Sources:
Scientific Industries Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Scientific Industries Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.